You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letters
Topical timolol maleate 0.5% for infantile capillary haemangioma of the eyelid
  1. Kanmin Xue1,2,
  2. Göran Darius Hildebrand1,2
  1. 1Department of Paediatric Ophthalmology, Prince Charles Eye Unit, King Edward VII Hospital, Windsor, Berkshire, UK
  2. 2Royal Berkshire NHS Foundation Hospital, Reading, UK
  1. Correspondence to Göran Darius Hildebrand, Prince Charles Eye Unit, King Edward VII Hospital, St Leonard's Road, Windsor, Berkshire SL4 3DP, UK; darius.hildebrand{at}royalberkshire.nhs.uk

https://doi.org/10.1136/bjophthalmol-2012-302396

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with great interest the recent article ‘Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients’, advocating oral propranolol as first-line therapy for periocular capillary haemangiomas.1 We would like to add topical timolol to the available treatment options, which was not mentioned in the article.

    It has been the experience of several published cohorts, as well as our own …

    View Full Text

    Footnotes

    • Contributors Both authors contributed to the writing of the article.

    • Funding This work received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

    • Conflict of interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.